HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erythropoietin increases neuronal NDPKA expression, and NDPKA up-regulation as well as exogenous application protects cortical neurons from in vitro ischemia-related insults.

Abstract
Using proteomics, we identified nucleoside diphosphate kinase A (NDPKA; also known as NME/NM23 nucleoside diphosphate kinase 1: NME1) to be up-regulated in primary cortical neuronal cultures by erythropoietin (EPO) preconditioning. To investigate a neuroprotective role of NDPKA in neurons, we used a RNAi construct to knock-down and an adenoviral vector to overexpress the protein in cortical neuronal cultures prior to exposure to three ischemia-related injury models; excitotoxicity (L-glutamic acid), oxidative stress (hydrogen peroxide), and in vitro ischemia (oxygen-glucose deprivation). NDPKA down-regulation had no effect on neuronal viability following injury. By contrast, NDPKA up-regulation increased neuronal survival in all three-injury models. Similarly, treatment with NDPKA recombinant protein increased neuronal survival, but only against in vitro ischemia and excitotoxicity. These findings indicate that the NDPKA protein may confer a neuroprotective advantage following injury. Furthermore, as exogenous NDPKA protein was neuroprotective, it suggests that a cell surface receptor may be activated by NDPKA leading to a protective cell-signaling response. Taken together both NDPKAs intracellular and extracellular neuroprotective actions suggest that the protein is a legitimate therapeutic target for the design of drugs to limit neuronal death following stroke and other forms of brain injury.
AuthorsJonathan Teoh, Sherif Boulos, Joanne Chieng, Neville W Knuckey, Bruno P Meloni
JournalCellular and molecular neurobiology (Cell Mol Neurobiol) Vol. 34 Issue 3 Pg. 379-92 (Apr 2014) ISSN: 1573-6830 [Electronic] United States
PMID24395206 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Neuroprotective Agents
  • Erythropoietin
  • Nucleoside-Diphosphate Kinase
  • nucleoside diphosphate kinase, rat
Topics
  • Animals
  • Brain Ischemia (metabolism, prevention & control)
  • Cell Survival (drug effects, physiology)
  • Cells, Cultured
  • Cerebral Cortex (drug effects, metabolism)
  • Erythropoietin (pharmacology, therapeutic use)
  • Gene Expression Regulation
  • HEK293 Cells
  • Humans
  • Neurons (drug effects, metabolism)
  • Neuroprotective Agents (pharmacology, therapeutic use)
  • Nucleoside-Diphosphate Kinase (biosynthesis, pharmacology, therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Up-Regulation (drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: